Does selective ablation of Notch3 in HCC enhance doxorubicin 's death promoting effect by a p53 dependent mechanism?
Our in vitro results represent the first evidence that Notch3 silencing in combination with chemotherapeutics could conceivably provide a novel strategy for HCC treatment that deserves further exploration.
Microparticles from HUVEC could promote the migration of monocytes. As carriers, microparticles could mediate intercellular signaling.